In this study, novel 4-(4-chlorophenyl)-N-phenyl-3-(pyridin-4-yl)thiazol-2(3H)-imine derivative (2) has been synthesized and the structure of the compound has been investigated by spectral analysis methods. By 1H-NMR and 13C-NMR spectral analysis, it was determined that the compound was obtained purely and its structure was elucidated. Further characterization of the compound 2D-NMR has been used to confirm the ring closure of the thiazole and the positions of the substituents linked carbon atoms. In silico studies have been completed via SwissADME and pkCSM pharmacokinetics software programs. The SwissADME software predicted that compound 2 could cross the blood-brain barrier (BBB) and also enter the gastrointestinal system. pkCSM pharmacokinetics studies indicated that compound 2 has no hepatotoxicity and also shows no skin irritation.
| Primary Language | English |
|---|---|
| Subjects | Pharmacology and Pharmaceutical Sciences (Other) |
| Journal Section | Research Article |
| Authors | |
| Submission Date | February 24, 2025 |
| Acceptance Date | March 22, 2025 |
| Publication Date | April 30, 2025 |
| Published in Issue | Year 2025 Volume: 4 Issue: 1 |
Announcement
Dear Readers, Authors, and Reviewers,
An inconsistency has been identified in the automatically generated editorial board information due to a technical issue in the infrastructure that enables the electronic management of our journal. As a result of this technical problem, the current editorial board information can be accessed on DergiPark at https://dergipark.org.tr/en/pub/ejls/board.
However, the editorial board and reviewer information for a published issue are included in the PDF file of the relevant issue. Therefore, the accurate and authoritative information should be accessed through the PDF of the respective issue.
For your information.
**Click here for an important announcement regarding the Editorial Board.**